Tango Therapeutics, Inc.

NASDAQ (USD): Tango Therapeutics, Inc. (TNGX)

Last Price

8.28

Today's Change

0.00 (0.00%)

Day's Change

8.26 - 8.67

Trading Volume

412,117

Overview

Market Cap

887 Million

Shares Outstanding

107 Million

Avg Volume

903,328

Avg Price (50 Days)

9.93

Avg Price (200 Days)

9.40

PE Ratio

-7.46

EPS

-1.11

Earnings Announcement

06-Nov-2024

Previous Close

8.28

Open

8.51

Day's Range

8.26 - 8.67

Year Range

5.15 - 13.03

Trading Volume

412,732

Price Change Highlight

1 Day Change

0.00%

5 Day Change

-18.42%

1 Month Change

-22.47%

3 Month Change

-13.30%

6 Month Change

1.60%

Ytd Change

-17.03%

1 Year Change

-2.82%

3 Year Change

-50.12%

5 Year Change

-19.06%

10 Year Change

-19.06%

Max Change

-19.06%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment